Rockwell Medical, Inc. (RMTI) is a Healthcare stock trading at $8.00 (as of 2026-08-21), with a market capitalization of $315.76M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Rockwell Medical is a healthcare company focused on pharmaceutical products, making money by selling its pharmaceutical products to customers.
With gross margin 17% but operating margin -8%, the profit model currently converts insufficient gross profit into operating earnings.
Business quality (Weak): Business quality grade is Weak.
| Price | $8.00 |
| Market Cap | $315.76M |
| Price / Book | 8.81 |
| Price / Sales | 4.63 |
| FCF Yield | -3.0% |
| Revenue (TTM) | $69.26M |
| Net Margin | -7.7% |
| Revenue Growth (YoY) | -31.8% |
| EPS Growth (YoY) | 400.0% |
| FCF Growth (YoY) | -137.6% |
| Altman Z-Score | 1.05 (distress) |
| Piotroski F-Score | 2/9 (weak) |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector | Healthcare |
| Industry | Pharmaceutical Products |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.